Inovox orange

Medicinal product

(Invented) name

Inovox orange

Active substance (s)

Lidokaino hidrochloridas monohidratas/Amilmetakrezolis/2,4-dichlorobenzilo alkoholis

Strength

2 mg/0,6 mg/1,2 mg

Pharmaceutical form

kietosios pastilės

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

ATC code (s)

R02AA20, Various

Marketing authorisation holder

US Pharmacia Sp. z o.o., Lenkija

Date of authorisation

2017-11-13

Date of renewal

2022-06-09

Documents

Stage

Perregistruotas

Controlled?

Controlled substance type

Legal basis

10(3)

Procedure number

PL/H/0507/002

Marketing authorisation procedure

Kartotinė procedūra

Qualitative and quantitative composition

Pastilėje yra	1 vnt.
Lidokaino hidrochloridas monohidratas	2 mg
Amilmetakrezolis	0,6 mg
2,4-dichlorobenzilo alkoholis	1,2 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
98292	84390	1084390	lizdinė plokštelė	N12	Nereceptinis	LT/1/17/4160/001	Netiekiama	-	-	No	-	-
98295	84393	1084393	lizdinė plokštelė	N24	Nereceptinis	LT/1/17/4160/002	Tiekiama	-	-	No	-	-	Download
99149	85255	1085255	lizdinė plokštelė	N36	Nereceptinis	LT/1/17/4160/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-06-09	Perregistruotas
2017-11-13	Registruotas